Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions

Expert Rev Neurother. 2015 Apr;15(4):367-80. doi: 10.1586/14737175.2015.1018892. Epub 2015 Feb 26.

Abstract

Aneurysmal subarachnoid hemorrhage is the most devastating form of stroke. Many pathological mechanisms ensue after cerebral aneurysm rupture, including hydrocephalus, apoptosis of endothelial cells and neurons, cerebral edema, loss of blood-brain barrier, abnormal cerebral autoregulation, microthrombosis, cortical spreading depolarization and macrovascular vasospasm. Although studied extensively through experimental and clinical trials, current treatment guidelines to prevent delayed cerebral ischemia is limited to oral nimodipine, maintenance of euvolemia, induction of hypertension if ischemic signs occur and endovascular therapy for patients with continued ischemia after induced hypertension. Future investigations will involve agents targeting vasodilation, anticoagulation, inhibition of apoptosis pathways, free radical neutralization, suppression of cortical spreading depolarization and attenuation of inflammation.

Keywords: cerebral aneurysm; cortical spreading depolarization; delayed cerebral ischemia; early brain injury; endothelial cells; inflammation; smooth muscle cell; subarachnoid hemorrhage; vasospasm.

Publication types

  • Review

MeSH terms

  • Blood-Brain Barrier / physiopathology
  • Cortical Spreading Depression
  • Disease Management*
  • Disease Progression
  • Humans
  • Hydrocephalus / etiology
  • Hypertension / etiology
  • Intracranial Aneurysm* / complications
  • Intracranial Aneurysm* / pathology
  • Intracranial Aneurysm* / therapy
  • Subarachnoid Hemorrhage* / complications
  • Subarachnoid Hemorrhage* / pathology
  • Subarachnoid Hemorrhage* / therapy
  • Vasospasm, Intracranial / etiology